Disclosure 0002091798-26-000010-1

SEC FORM 4

$16,288.72

SERA PROGNOSTICS, INC. (SERA)

Sale of 8,024 shares at $2.03 per share.

Reporting Person Inglis Tiffany Eul Davis · Officer Title Chief Medical Officer · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0002091798-26-000010 · filed 2026-10-13 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "SERA PROGNOSTICS, INC. (SERA)." Disclosed 2026-10-13. https://desqlong.com/cards/0002091798-26-000010-1 (retrieved 2026-10-14).